Edward Wholihan, Allena Pharmaceuticals, Inc.'s Chief Financial Officer, recently acquired 96,272 shares of the company. The buys took place at prices ranging from $0.00 to $1.36 per share, on December 17, 2020. Wholihan now owns 189,822 shares of the company. Wholihan operates out of Newton, MA. Some additional info was provided as follows:
The sale reported on this Form 4 was effected by the Reporting Person and represents shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units
Each restricted stock unit represents a contingent right to receive one share of common stock.
On December 2, 2019, the Reporting Person was granted 82,411 restricted stock units, vesting in two equal installments on June 2, 2020 and December 2, 2020 (the "December 2019 Grant"). On May 28, 2020, the reporting person was granted an additional 82,411 restricted stock units (the "May 2020 Grant") and the December 2019 Grant was amended to vest in full, together with the May 2020 Grant, on December 2, 2020. 164,822 shares of common stock were distributed to the Reporting Person on December 17, 2020 following the vesting of the restricted stock units from the December 2019 Grant and the May 2020 Grant.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Allena Pharmaceuticals, Inc. makes a similar move, sign up!
Other recent filings from the company include the following: